Zag Bio
Series AZag Bio is a privately held company based in United States, founded in 2022. The latest disclosed round is Series A ($80m), dated Oct 28, 2025. Institutional investors on record include Lightspeed Venture Partners.
United States · EST 2022
What is Zag Bio?
Zag Bio is a privately held company based in United States, founded in 2022. The latest disclosed round is Series A ($80m), dated Oct 28, 2025. Institutional investors on record include Lightspeed Venture Partners. Developer of thymus-targeted medicines for autoimmune disease treatment and prevention. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
Which funds backed Zag Bio?
Who invested in Zag Bio?
Funds on the dated round table. Open a name to read the fund card.
| Investor | Round | Amount | Date |
|---|---|---|---|
| Lightspeed Venture Partners | Series A | $80m | Oct 28, 2025 |
What do founders ask about Zag Bio?
What is Zag Bio?
Zag Bio is a privately held company based in United States, founded in 2022. The latest disclosed round is Series A ($80m), dated Oct 28, 2025. Institutional investors on record include Lightspeed Venture Partners. Developer of thymus-targeted medicines for autoimmune disease treatment and prevention. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
What was Zag Bio's last funding round?
Zag Bio's latest disclosed round is Series A at $80m (Oct 28, 2025).
Who invested in Zag Bio?
Zag Bio has 1 institutional investors on this page, including Lightspeed Venture Partners.
How does CrackTheDeck cover Zag Bio?
This startup card lists dated rounds and linked fund profiles so founders can see who is already in the cap table before a pitch.
How is this page compiled?
Round, amount, and investor names on the Zag Bio card come from dated financings linked to fund profiles in CrackTheDeck. Empty fields mean the figure was not in those records. Updated Aug 2026.